Anti-c-Myb 抗体 (ab117635)
Key features and details
- Rabbit polyclonal to c-Myb
- Suitable for: WB, IHC-P, ICC/IF
- Reacts with: Human
- Isotype: IgG
リコンビナント抗体で、ロット間での高い再現性を実現
- 異なるロット間での安定した再現性
- 容易なスケールアップ
- 評価試験による特異性の確認済み
- 倫理基準に準拠 - アニマル・フリーの生産
製品の概要
-
製品名
Anti-c-Myb antibody
c-Myb 一次抗体 製品一覧 -
製品の詳細
Rabbit polyclonal to c-Myb -
由来種
Rabbit -
アプリケーション
適用あり: WB, IHC-P, ICC/IFmore details -
種交差性
交差種: Human
交差が予測される動物種: Mouse -
免疫原
KLH-conjugated synthetic peptide derived from the N terminal region of Human c-Myb.
-
ポジティブ・コントロール
- Human breast or tonisl tissue. HUVEC cell lysate. HeLa cells.
-
特記事項
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at -20°C or -80°C. Avoid freeze / thaw cycle. Store undiluted. -
バッファー
pH: 7.40
Preservative: 0.02% Sodium azide
Constituents: 50% Glycerol (glycerin, glycerine), 0.88% Sodium chloride, 48% PBS -
Concentration information loading...
-
精製度
Immunogen affinity purified -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
関連製品
-
Compatible Secondaries
-
Isotype control
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab117635の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
WB |
1/500 - 1/1000. Predicted molecular weight: 72 kDa.
|
|
IHC-P |
Use a concentration of 5 µg/ml.
|
|
ICC/IF | (1) |
1/100 - 1/500.
|
特記事項 |
---|
WB
1/500 - 1/1000. Predicted molecular weight: 72 kDa. |
IHC-P
Use a concentration of 5 µg/ml. |
ICC/IF
1/100 - 1/500. |
ターゲット情報
-
機能
Transcriptional activator; DNA-binding protein that specifically recognize the sequence 5'-YAAC[GT]G-3'. Plays an important role in the control of proliferation and differentiation of hematopoietic progenitor cells. -
配列類似性
Contains 3 HTH myb-type DNA-binding domains. -
ドメイン
Comprised of 3 domains; an N-terminal DNA-binding domain, a centrally located transcriptional activation domain and a C-terminal domain involved in transcriptional repression. -
翻訳後修飾
Ubiquitinated; mediated by SIAH1 and leading to its subsequent proteasomal degradation.
Phosphorylated by NLK on multiple sites, which induces proteasomal degradation. -
細胞内局在
Nucleus. - Information by UniProt
-
参照データベース
- Entrez Gene: 4602 Human
- Entrez Gene: 17863 Mouse
- Omim: 189990 Human
- SwissProt: P10242 Human
- SwissProt: P06876 Mouse
- Unigene: 606320 Human
- Unigene: 52109 Mouse
-
別名
- C myb antibody
- c myb protein (140 AA) antibody
- c-myb protein (140 AA) antibody
see all
画像
-
All lanes : Anti-c-Myb antibody (ab117635) at 1/500 dilution
Lane 1 : HUVEC cell lysate
Lane 2 : HUVEC cell lysate with synthetic peptide
Predicted band size: 72 kDa -
Immunofluorescence analysis of HeLa cells, using 1/100 ab117635.
The picture on the right is treated with the synthesized peptide. -
Human Breast, Formalin-Fixed, Paraffin-Embedded tissue, stained with ab117635 at 5µg/ml.
-
Human Tonsil, Formalin-Fixed, Paraffin-Embedded tissue, stained with ab117635 at 5µg/ml.
プロトコール
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (7)
ab117635 は 7 報の論文で使用されています。
- Liu Q et al. Brucine inhibits proliferation of glioblastoma cells by targeting the G-quadruplexes in the c-Myb promoter. J Cancer 12:1990-1999 (2021). PubMed: 33753997
- Simeoni F et al. Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia. Cell Rep 36:109725 (2021). PubMed: 34551306
- Kodric K et al. Sex-determining region Y (SRY) attributes to gender differences in RANKL expression and incidence of osteoporosis. Exp Mol Med 51:1-16 (2019). PubMed: 31409771
- Felipe-Abrio B et al. Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer. Cancers (Basel) 11:N/A (2019). PubMed: 30781655
- Xie R et al. c-Myb and its Effector COX-2 as an Indicator Associated with Prognosis and Therapeutic Outcome in Colorectal Cancer. J Cancer 10:1601-1610 (2019). PubMed: 31205515
- Ringleb J et al. Apoptotic Cancer Cells Suppress 5-Lipoxygenase in Tumor-Associated Macrophages. J Immunol 200:857-868 (2018). PubMed: 29229677
- Tosello V et al. A Novel t(8;14)(q24;q11) Rearranged Human Cell Line as a Model for Mechanistic and Drug Discovery Studies of NOTCH1-Independent Human T-Cell Leukemia. Cells 7:N/A (2018). PubMed: 30304769